There are many factors which can affect a patients HbA1c value which can lead to clinically misleading results. Sebia are hosting a webinar to identify and explain these variations and how they should be managed.
Join us on Tuesday 15th June along with speakers: David B. Sacks, Senior Investigator and Chief at NIH, Chairman of the NGSP Steering Committee; and John Higgins, Associate Professor at Harvard Medical School and Associate Pathologist at Massachusetts General Hospital.
The learning objectives of this talk will be:
- Identify components contributing to glycation rate of Hb to form Hb A1c
- Discuss which conditions can cause an artificial decrease/reduction in the levels of circulating Hb A1c
- Review which conditions should prevent the use of HbA1c for monitoring/diagnosing diabetic patients
- Identify methods that indicate the presence of clinically significant hemoglobinopathies and/or thalassemia’s
To register click here
